protein that is highly induced by tumor necrosis factor-alpha and adipose conversion. J Biol Chem 276: 33938–33946. 7. Korkmaz KS, Elbi C, Korkmaz CG, Loda M, Hager GL, et al. (2002) Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem 277: 36689–36696. 8. MacDonald SM, Bhisutthibhan J, Shapiro TA, Rogerson SJ, Taylor TE, et al. (2001) Immune mimicry in malaria: Plasmodium falciparum secretes a functional histamine-releasing factor homolog in vitro and in vivo. Proc Natl Acad Sci U S A 98: 10829–10832. 9. Rao KV, Chen L, Gnanasekar M, Ramaswamy K (2002) Cloning and characterization of a calcium-binding, histamine-releasing protein from Schistosoma mansoni. J Biol Chem 277: 31207–31213. 10. Gnanasekar M, Rao KV, Chen L, Narayanan RB, Geetha M, et al. (2002) Molecular characterization of a calcium binding translationally controlled tumor protein homologue from the filarial parasites Brugia malayi and Wuchereria bancrofti. Mol Biochem Parasitol 121: 107–118. 11. Schroeder JT, Lichtenstein LM, MacDonald S (1996) An immunoglobulin E dependent recombinant histamine releasing factor induces IL-4 secretion from human basophils. J Exp Med 183: 1265–1270. 12. Schroeder JT, Lichtenstein LM, MacDonald SM (1997) Recombinant histamine-releasing factor enhances IgE dependent IL-4 and IL-13 secretion by human basophils. J Immunol 159: 447–452. 13. Bheekha-Escura R, Chance SR, Langdon JM, Jr., MacGlashan DW, MacDonald SM (1999) Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor. J Allergy Clin Immunol 103: 937–943. 14. Wantke F, MacGlashan DW, Langdon JM, MacDonald SM (1999) The human recombinant histamine releasing factor: Functional evidence that it does not bind to the IgE molecule. J Allergy Clin Immunol 103: 642–648. 15. Bheekha-Escura R, MacGlashan DW, Langdon JM, MacDonald SM (2000) Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10. Blood 96: 2191–2198. 16. Vonakis BM, Sora R, Langdon JM, Casolaro V, MacDonald SM (2003) Inhibition of cytokine gene transcription by the human recombinant histamine- releasing factor in human T lymphocytes. J Immunol 17: 3742–3750. 17. Kang HS, Lee MJ, Song H, Han SH, Kim YM, et al. (2001) Molecular identification of IgE-dependent histamine-releasing factor as a B cell growth factor. J Immunol 166: 6545–6554. 18. Yoneda K, Rokutan K, Nakamura Y, Yanagawa H, Kondo-Teshima S, et al. (2004) Stimulation of human bronchial epithelial cells by IgE-dependent histamine-releasing factor. Am J Physiol Lung Cell Mol Physiol 286: L174–L181. 19. MacDonald SM, Lichtenstein LM, Proud D, Plaut M, Naclerio RM, et al. (1987) Studies of IgE-dependent histamine-releasing factorS: heterogeneity of IgE. J Immunol 139: 506–512. 20. MacDonald SM. Histamine releasing factors and IgE heterogeneity. In: Allergy: Principles and Practice, Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. 4th Edition, 1993, pp 1–11. 21. Iliopoulos O, Proud D, Adkinson NF, Jr., Norman PS, Kagey-Sobotka A, et al. (1990) Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol 86: 851–861. HRF Transgenic Mice Phenotype 22. Sampson HS, Broadbent KR, Bernhisel-Broadbent J (1989) Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 321: 228–232. 23. Chen SH, Wu PS, Chou CH, Yan YT, Liu H, et al. (2007) A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. Mol Cell Biol 18: 2525–2533. 24. Brusselle GC, Kips JC, Peleman RA, Joos GF, Devos RR, et al. (1997) Role of IFN-c in the inhibition of the allergic airway inflammation caused by IL-12. Cell Mol Biol 17: 767–771. 25. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, et al. (1997) Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156: 766–775. 26. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, et al. (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103: 779–788. 27. Langdon JM, Vonakis BM, MacDonald SM (2004) Identification of the Interaction between the Human Recombinant Histamine Releasing Factor/ Translationally Controlled Tumor Protein and Elongation Factor-1 delta (also known as eElongation Factor-1B beta). Biochem Biophys Acta 1688: 232–236. 28. Melgarejo E, Medina MA, Sa´nchez-Jime´nez F, Urdiales JL (2009) Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 41: 998–1001. 29. Teshima S, Rokutan K, Nikawa T, Kishi K (1998) Macrophage colony- stimulating factor stimulates synthesis and secretion of a mouse homolog of a human IgE-dependent histamine-releasing factor by macrophages in vitro and in vivo. J Immunol 161: 6356–6366. 30. Yarm ER (2002) PlK phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol Cell Biol 22: 6209–6221. 31. Cohn L, Tepper JS, Bottomly K (1998) IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J Immunol 161: 3813–3816. 32. Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K (1997) Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 186: 1737–1747. 33. Warner JA, Pienkowski MM, Plaut M, Norman PS, Lichtenstein LM (1986) Identification of histamine releasing factor(s) in the late phase of ctaneous IgE- mediated reactions. J Immunol 136: 2583–2587. 34. Min B, Paul W (2008) Basophils and type 2 immunity. Curr Opin Hematol 15: 59–63. 35. Obata K, Mukai K, Tsujimura Y, Ishiwata K, Kawano Y, et al. (2007) Basophils are essential initiators of a novel type of chronic allergic inflammation. Blood 110: 913–920. 36. Schroeder JT, Lichtenstein LM, Roche EM, Xiao H, Liu MC (2001) IL-4 production by human basophils found in the lung following segmental allergen challenge. J Allergy Clin Immunol 107: 265–271. 37. Sokol CL, Barton GM, Farr AG, Medzhitov R (2008) A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 9: 310–308. 38. Tuynder M, Fiucci G, Prieur S, Lespagnol A, Ge´ant A, et al. (2004) Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci U S A 101: 15364–15369. PLoS ONE | www.plosone.org 12 June 2010 | Volume 5 | Issue 6 | e11077